Friday, 23 March 2018

GSK's two-drug HIV regimen wins European panel approval

(Reuters) - A panel of European Medicines Agency on Friday recommended approval for GlaxoSmithKline's two-drug regimen to treat HIV, the virus that causes AIDS.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)